DOXORUBICIN

Clinical trials for DOXORUBICIN explained in plain language.

Never miss a new study

Get alerted when new DOXORUBICIN trials appear

Sign up with your email to follow new studies for DOXORUBICIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New drug combo shows promise in hodgkin lymphoma battle

Disease control Completed

This study tested a new drug combination (brentuximab vedotin plus AVD) against the standard treatment (ABVD) for people with advanced Hodgkin lymphoma. Sixty adults aged 18-70 with stage III or IV disease took part. The goal was to see which treatment worked better at controllin…

Matched conditions: DOXORUBICIN

Phase: NA • Sponsor: Helwan University • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

DOXORUBICIN

Get alerted when new DOXORUBICIN trials appear

New drug combo shows promise in hodgkin lymphoma battle